How the drug abemaciclib treats breast cancer
The anti-cancer drug abemaciclib (also known as Vernezio) has been added to the Australian Pharmaceutical Benefits Scheme (PBS) to treat certain types of breast cancer.
May 7, 2024
0
0
The anti-cancer drug abemaciclib (also known as Vernezio) has been added to the Australian Pharmaceutical Benefits Scheme (PBS) to treat certain types of breast cancer.
May 7, 2024
0
0
A new study, led by Prof. Liu from the department of pharmacy, University of Electronic Science and Technology of China, discovered that the extracellular cell matrix (ECM) could induce the drug resistance of breast cancer ...
Apr 8, 2024
0
7
Triple-negative breast cancer (TNBC) is difficult to treat due to its aggressive nature and resistance to chemotherapy. Exciting research published by the University of Southern Denmark sheds light on the mechanisms that ...
Apr 2, 2024
0
49
In 2020, the most recent year with data on cancer cases, 452 people under the age of 55 received a colorectal cancer diagnosis in Colorado, up from 367 a decade earlier—a 23% increase.
Mar 20, 2024
0
0
The first over-the-counter (OTC) birth control pill, Opill, will be available at pharmacies, convenience stores, grocery stores and on the Opill.com website later this month or early April.
Mar 9, 2024
0
0
Male breast cancer has distinct alterations in the tumor genome that may suggest potential treatment targets, according to a study by Weill Cornell Medicine investigators. They have conducted the first whole genome sequencing ...
Mar 4, 2024
0
0
An important discovery from the NCI-MATCH precision medicine initiative is published in Clinical Cancer Research.
Mar 4, 2024
0
5
Monash University-led research is using math to predict how new combination therapies can help patients with breast cancer who no longer respond to conventional therapies.
Feb 5, 2024
0
38
A promising drug could lead to a new treatment for the most aggressive form of breast cancer, which affects thousands of women each year. A pre-clinical study led by the University of Adelaide found the new drug successfully ...
Feb 5, 2024
0
41
A multidisciplinary team of researchers that included 14 graduate students from The University of Texas at Arlington has created a new framework to provide optimal personalized treatment options for individuals with esophageal ...
Jan 31, 2024
0
0